共 50 条
- [11] Disulfide bridge formation contributes to histone ligand recognition by the ATAD2 bromodomainFASEB JOURNAL, 2018, 32 (01):Evans, ChiaraGay, JamieEckenroth, Brian E.Carlson, SamuelLloyd, Jonathan T.Glass, Karen C.
- [12] Potent and isoform-selective ATAD2 bromodomain inhibitor with unprecedented chemical structure and mode of actionCANCER RESEARCH, 2017, 77Fernandez-Montalvan, Amaury E.Berger, MarkusKuropka, BennoKoo, Seong JooBadock, VolkerWeiske, JoergHolton, Simon J.Chaikuad, ApiratDiaz-Saez, LauraBennett, JamesFederov, OlegHuber, KilianCentrella, PaoloClark, Matthew A.Dumelin, Christoph E.Sigel, Eric A.Soutter, Holly S.Troast, Dawn M.Zhang, YingCuozzo, John W.Keefe, Anthony D.Roche, DidierRodeschini, VincentHuebner, JanWeinmann, HilmarHartung, Ingo V.Gorjanacz, Matyas
- [13] Structure-based approaches towards identification of fragments for the low-druggability ATAD2 bromodomainMEDCHEMCOMM, 2014, 5 (12) : 1843 - 1848Chaikuad, ApiratPetros, Andrew M.Fedorov, OlegXu, JingKnapp, Stefan
- [14] Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain BlockersACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (08): : 1573 - 1580Dolbois, AymericBatiste, LaurentWiedmer, LarsDong, JingBrutsch, ManuelaHuang, DanzhiDeerain, Nicholas M.Spiliotopoulos, DimitriosCheng-Sanchez, IvanLaul, EleenNevado, CristinaSledz, PawelCaflisch, Amedeo
- [15] Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain InhibitorsJOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (14) : 5649 - 5673Demont, Emmanuel H.Chung, Chun-waFurze, Rebecca C.Grandi, PaolaMichon, Anne-MarieWellaway, ChrisBarrett, NathalieBridges, Angela M.Craggs, Peter D.Diallo, HawaDixon, David P.Douault, ClementEmmons, Amanda J.Jones, Emma J.Karamshi, Bhumika V.Locke, KellyMitchell, Darren J.Mouzon, Bernadette H.Prinjha, Rab K.Roberts, Andy D.Sheppard, Robert J.Watson, Robert J.Bamborough, Paul
- [17] Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding ModeJOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (10) : 5212 - 5241Lucas, Simon C. C.Atkinson, Stephen J.Bamborough, PaulBarnett, HeatherChung, Chun-waGordon, LaurieMitchell, Darren J.Phillipou, AlexanderPrinjha, Rab K.Sheppard, Robert J.Tomkinson, Nicholas C. O.Watson, Robert J.Demont, Emmanuel H.
- [18] Reading the message: A structural and functional comparison of the ATAD2/B bromodomain binding activityACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2022, 78 : A100 - A100Glass, Karen
- [19] Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer ModelsJOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 3306 - 3331Winter-Holt, Jon J.Bardelle, CatherineChiarparin, ElisabettaDale, Ian L.Davey, Paul R. J.Davies, Nichola L.Denz, ChristopherFillery, Shaun M.Guerot, Carine M.Han, FujinHughes, Samantha J.Kulkarni, MeghanaLiu, ZhaoqunMilbradt, AlexanderMoss, Thomas A.Niu, HuijunPatel, JoeRabow, Alfred A.Schimpl, MarianneShi, JunjieSun, DongqingYang, DejianGuichard, Sylvie
- [20] Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screeningJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 713 - 725Yao, DahongZhang, JinWang, JinhuiPan, DaboHe, Zhendan